215 related articles for article (PubMed ID: 22279592)
1. ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers.
Vermeer PD; Bell M; Lee K; Vermeer DW; Wieking BG; Bilal E; Bhanot G; Drapkin RI; Ganesan S; Klingelhutz AJ; Hendriks WJ; Lee JH
PLoS One; 2012; 7(1):e30447. PubMed ID: 22279592
[TBL] [Abstract][Full Text] [Related]
2. Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathway.
Hoover AC; Strand GL; Nowicki PN; Anderson ME; Vermeer PD; Klingelhutz AJ; Bossler AD; Pottala JV; Hendriks WJ; Lee JH
Oncogene; 2009 Nov; 28(45):3960-70. PubMed ID: 19734941
[TBL] [Abstract][Full Text] [Related]
3. Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
Zhu JH; Chen R; Yi W; Cantin GT; Fearns C; Yang Y; Yates JR; Lee JD
Oncogene; 2008 Apr; 27(18):2525-31. PubMed ID: 17982484
[TBL] [Abstract][Full Text] [Related]
4. EphrinB1: novel microtubule associated protein whose expression affects taxane sensitivity.
Colbert PL; Vermeer DW; Wieking BG; Lee JH; Vermeer PD
Oncotarget; 2015 Jan; 6(2):953-68. PubMed ID: 25436983
[TBL] [Abstract][Full Text] [Related]
5. PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.
Glondu-Lassis M; Dromard M; Lacroix-Triki M; Nirdé P; Puech C; Knani D; Chalbos D; Freiss G
Cancer Res; 2010 Jun; 70(12):5116-26. PubMed ID: 20501847
[TBL] [Abstract][Full Text] [Related]
6. VRK2 inhibits mitogen-activated protein kinase signaling and inversely correlates with ErbB2 in human breast cancer.
Fernández IF; Blanco S; Lozano J; Lazo PA
Mol Cell Biol; 2010 Oct; 30(19):4687-97. PubMed ID: 20679487
[TBL] [Abstract][Full Text] [Related]
7. The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer.
Scrima M; De Marco C; De Vita F; Fabiani F; Franco R; Pirozzi G; Rocco G; Malanga D; Viglietto G
Am J Pathol; 2012 Mar; 180(3):1202-1214. PubMed ID: 22245727
[TBL] [Abstract][Full Text] [Related]
8. EphrinB1 interacts with CNK1 and promotes cell migration through c-Jun N-terminal kinase (JNK) activation.
Cho HJ; Hwang YS; Mood K; Ji YJ; Lim J; Morrison DK; Daar IO
J Biol Chem; 2014 Jun; 289(26):18556-68. PubMed ID: 24825906
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of EphrinB1 is associated with lymph node metastasis and poor prognosis in breast cancer.
Yin H; Lu C; Tang Y; Wang H; Wang H; Wang J
Cancer Biomark; 2013; 13(4):261-7. PubMed ID: 24240587
[TBL] [Abstract][Full Text] [Related]
10. ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells.
Haenssen KK; Caldwell SA; Shahriari KS; Jackson SR; Whelan KA; Klein-Szanto AJ; Reginato MJ
J Cell Sci; 2010 Apr; 123(Pt 8):1373-82. PubMed ID: 20332114
[TBL] [Abstract][Full Text] [Related]
11. A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells.
Arias-Romero LE; Villamar-Cruz O; Pacheco A; Kosoff R; Huang M; Muthuswamy SK; Chernoff J
Oncogene; 2010 Oct; 29(43):5839-49. PubMed ID: 20711231
[TBL] [Abstract][Full Text] [Related]
12. PTPN13 acts as a tumor suppressor in clear cell renal cell carcinoma by inactivating Akt signaling.
Long Q; Sun J; Lv J; Liang Y; Li H; Li X
Exp Cell Res; 2020 Nov; 396(1):112286. PubMed ID: 32919955
[TBL] [Abstract][Full Text] [Related]
13. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
Contessa JN; Abell A; Mikkelsen RB; Valerie K; Schmidt-Ullrich RK
Breast Cancer Res Treat; 2006 Jan; 95(1):17-27. PubMed ID: 16267617
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells.
Lu Y; Zi X; Zhao Y; Pollak M
Biochem Biophys Res Commun; 2004 Jan; 313(3):709-15. PubMed ID: 14697248
[TBL] [Abstract][Full Text] [Related]
15. Signaling by ephrinB1 and Eph kinases in platelets promotes Rap1 activation, platelet adhesion, and aggregation via effector pathways that do not require phosphorylation of ephrinB1.
Prévost N; Woulfe DS; Tognolini M; Tanaka T; Jian W; Fortna RR; Jiang H; Brass LF
Blood; 2004 Feb; 103(4):1348-55. PubMed ID: 14576067
[TBL] [Abstract][Full Text] [Related]
16. ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells.
Hawthorne VS; Huang WC; Neal CL; Tseng LM; Hung MC; Yu D
Mol Cancer Res; 2009 Apr; 7(4):592-600. PubMed ID: 19372587
[TBL] [Abstract][Full Text] [Related]
17. Dual Role of the PTPN13 Tyrosine Phosphatase in Cancer.
Mcheik S; Aptecar L; Coopman P; D'Hondt V; Freiss G
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33322542
[TBL] [Abstract][Full Text] [Related]
18. Tyr-298 in ephrinB1 is critical for an interaction with the Grb4 adaptor protein.
Bong YS; Park YH; Lee HS; Mood K; Ishimura A; Daar IO
Biochem J; 2004 Jan; 377(Pt 2):499-507. PubMed ID: 14535844
[TBL] [Abstract][Full Text] [Related]
19. Copine-III interacts with ErbB2 and promotes tumor cell migration.
Heinrich C; Keller C; Boulay A; Vecchi M; Bianchi M; Sack R; Lienhard S; Duss S; Hofsteenge J; Hynes NE
Oncogene; 2010 Mar; 29(11):1598-610. PubMed ID: 20010870
[TBL] [Abstract][Full Text] [Related]
20. Protein-tyrosine phosphatase PTPN9 negatively regulates ErbB2 and epidermal growth factor receptor signaling in breast cancer cells.
Yuan T; Wang Y; Zhao ZJ; Gu H
J Biol Chem; 2010 May; 285(20):14861-14870. PubMed ID: 20335174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
